Neostigmine Reversal And Neuromuscular Recovery

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

April 30, 2017

Conditions
Residual Neuromuscular Block
Interventions
DRUG

Neostigmine Group

Neostigmine will be used to reverse neuromuscular block at the conclusion of the surgical procedure. The effect on muscle strength will be determined using the TOF-Watch-SX and clinical examination

OTHER

No Neostigmine group

Saline will be administered to patients at the end of the surgical procedure when neuromuscular function has recovered

Trial Locations (1)

60201

NorthShore University HealthSystem, Evanston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Endeavor Health

OTHER